You just read:

FDA Approves XCOPRI® (cenobamate tablets), an Anti-Epileptic Drug (AED) from SK Biopharmaceuticals, Co., Ltd., and U.S. Subsidiary SK Life Science, Inc.

News provided by

SK Life Science, Inc.

Nov 21, 2019, 18:10 ET